Question 1

What is the mechanism of action of masofaniten?

Accepted Answer

Masofaniten is designed to disrupt the androgen receptor (AR) signaling pathway, which is the primary driver of prostate cancer growth. By targeting this pathway, masofaniten aims to provide a new approach to treating prostate cancer.

Question 2

Is ESSA Pharma currently conducting any clinical trials?

Accepted Answer

Yes, ESSA Pharma is currently recruiting for clinical trials to evaluate the safety and efficacy of masofaniten. Interested individuals can learn more about the ongoing clinical trials on the company's website.

Question 3

What is the current status of ESSA Pharma's pipeline?

Accepted Answer

ESSA Pharma's lead clinical candidate, masofaniten, is currently in clinical development. The company provides regular updates on the progress of its pipeline, including any new developments or collaborations, through its press releases and investor communications.

Question 4

How can I stay informed about ESSA Pharma's activities?

Accepted Answer

Individuals can stay informed about ESSA Pharma's activities by visiting the company's website, subscribing to its press releases, and following the company on social media platforms such as Twitter and LinkedIn.

ESSA Pharmaceuticals Corp

Company Overview

Company Name

Address

Website

About ESSA Pharmaceuticals Corp

Frequently Asked Questions about ESSA Pharmaceuticals Corp

What is the mechanism of action of masofaniten?

Is ESSA Pharma currently conducting any clinical trials?

What is the current status of ESSA Pharma's pipeline?

How can I stay informed about ESSA Pharma's activities?

Technologies Used

Social Profiles